TXNIP and Hyperglycemia: Studies have demonstrated decreased skeletal muscle and blood TXNIP DNA methylation and increased skeletal muscle TXNIP expression in subjects both at increased risk of as well as overt T2DM, and hyperglycemia increases TXNIP expression in various cells and tissues [17, 18, 22].